Your browser doesn't support javascript.
loading
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC).
Ricciuti, Biagio; Jones, Greg; Severgnini, Mariano; Alessi, Joao V; Recondo, Gonzalo; Lawrence, Marissa; Forshew, Tim; Lydon, Christine; Nishino, Mizuki; Cheng, Michael; Awad, Mark.
Afiliación
  • Ricciuti B; Medical Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Jones G; Inivata, Research Triangle Park, North Carolina, USA.
  • Severgnini M; Medical Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Alessi JV; Center for Immuno-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Recondo G; Medical Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Lawrence M; Medical Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Forshew T; Medical Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Lydon C; Inivata, Research Triangle Park, North Carolina, USA.
  • Nishino M; Medical Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Cheng M; Radiology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Awad M; Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
J Immunother Cancer ; 9(3)2021 03.
Article en En | MEDLINE | ID: mdl-33771889
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / ADN Tumoral Circulante / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / ADN Tumoral Circulante / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos